Moffitt Cancer Center
Tampa, FL USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

New Moffitt Cancer Center Study Highlights Importance of Regular Lung Cancer Screenings for Those at High Risk

A new study by researchers at Moffitt Cancer Center found patients who tested negative for lung cancer by a detailed X-ray screening called low-dose helical computed tomography (LDCT) but later went on to develop lung cancer within the following two...
18-Aug-2016 9:05 AM EDT Add to Favorites

Moffitt Cancer Center Awarded $3.4 Million Grant to Establish Imaging Biomarker Validation Center

Early detection is one of the most effective strategies to save lives from most cancers. As part of a new U01 grant awarded to Jae K. Lee, PhD, Robert Gillies, PhD, John Heine, PhD and Matthew Schabath, PhD, the Moffitt Imaging Biomarker Validation...
13-Jul-2016 2:05 PM EDT Add to Favorites

Moffitt Cancer Center Awarded $3.2 Million Grant to Study Bone Metastasis in Prostate Cancer

Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis. Prostate cancer frequently spreads to the bone, and can cause painful bony lesion and increased mortality for...
13-Jul-2016 2:05 PM EDT Add to Favorites

Moffitt Cancer Center Launches Nationwide E-Cigarette Study

TAMPA, Fla. – The use of electronic cigarettes (“e-cigarettes”) has increased dramatically in recent years.  The majority of new “vapers” were already cigarette smokers.  To date, little is known about how e-cigarette use changes over...
11-Jul-2016 11:05 AM EDT Add to Favorites

Moffitt Researchers Find New Way to Control Genes Often Involved in Cancer Growth

Moffitt Cancer Center, a leader in molecular cancer research, and a research team led by Jia Fang, Ph.D., assistant member of the Tumor Biology Department, has discovered a new way to control the activity of SETDB1, a protein that is often...
8-Jul-2016 9:05 AM EDT Add to Favorites

Tumor Cells Develop Predictable Characteristics That Are Not Random, Say Moffitt Cancer Center Researchers

Moffitt Cancer Center researchers found that these assumptions may be incorrect. In a new article published in the journal Cancer Research, they report that certain subpopulations can be predicted and do not develop randomly as previously thought.
20-Jun-2016 2:05 PM EDT Add to Favorites

Moffitt Cancer Center Researchers Present Phase 1 Study Results of Selinexor Combination Therapy for Multiple Myeloma Patients

TAMPA, Fla. – Moffitt Cancer Center will present results from a phase 1 study of selinexor in combination with liposomal doxorubicin and dexamethasone in patients with relapsed and refractory multiple myeloma. The findings will be discussed...
6-Jun-2016 1:05 PM EDT Add to Favorites

Moffitt Cancer Center Finds Radiation Therapy with Pembrolizumab, Bevacizumab Safe for Recurrent High-Grade Glioma Patients

Moffitt Cancer Center will present preliminary results from a phase 1 study testing whether the addition of pembrolizumab to radiation therapy and bevacizumab is safe and can control tumor growth for these patients.
4-Jun-2016 9:05 AM EDT Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos





Chat now!